Philip Morris
Supplement to Application for Research Grant the Council for Tobacco Research Nicotine Effect Upon Cardiac Membrane Enzymes
Fields
- Author
- Brown, H.D.
- Chattopadhyay
- Patel, A.B.
- Chattopadhyay
- Area
- JOHN-WARE,JUDY/SHB FILE ROOM
- Type
- SCRT, SCIENTIFIC REPORT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART/GRAPH
- BIBL, BIBLIOGRAPHY
- Site
- R22
- Request
- Stmn/R1-037
- Named Organization
- Ctr, Council for Tobacco Research
- Named Person
- Awad
- Winer
- Document File
- 1003546610/1003547082/Meeting Scientific Advisory Board 670923 670924 Book 1 of 1
- Litigation
- Stmn/Produced
- Author (Organization)
- Univ of Tx
- Master ID
- 1003546610/7082
Related Documents:- 1003546610-7082 Meeting Scientific Advisory Board 670923 670 924 Book 1 of 1
- 1003546613-6616 Confidential Report Scientific Advisory Board Meeting New York, New York 670520 670521
- 1003546617-6619 Administrative Actions
- 1003546620-6622 Applications to Be Considered
- 1003546623-6627 Current Grants by Subject
- 1003546628-6633 Current Grants by Activation
- 1003546634 Renewals
- 1003546635-6636 Renewal Application From Herbert Mckennis, Jr., Ph.D. - No. 223-R8.
- 1003546637-6638
- 1003546639-6659 Application for Research Grant Factors Controlling the Biological Disposition of Pyridine Compounds of Tobacco Smoke
- 1003546660-6661 Application for Renewal and Extension From George O. Gey, M.D. - No. 361-R4.
- 1003546662-6681 Application for Research Grant Continuation of Studies on Characteristic of Normal Cell Growth in Relation to Invasive Carcinoma, Embryonal to Adult Forms. Support of Fellowships.
- 1003546682-6683 Renewal Application From Frederik B. Bang, M.D. - No. 409-R3
- 1003546684-6688 Application for Research Grant Pathogenesis of Virus Infections of Respiratory Mucosae
- 1003546689-6691 A Renewal Application From Charles L. Rose, A.M. And Benjamin Bell, M.D. - #455r1 .
- 1003546692-6701 Application for Research Grant Supplementary Assistance to the Normative Aging and Longevity Study.
- 1003546702-6703 Renewal Grant Application From Oswald Jones, M.D. - No. 523r1.
- 1003546704-6705
- 1003546706-6716 Application for Research Grant
- 1003546717-6718 Renewal Application From Gilbert H. Friedell, M.D. - No. 558-M-R1.
- 1003546719-6722 Application for Renewal of Research Grant the Pathogenesis of Human Bladder Cancer
- 1003546723-6725 the Pathogenesis of Human Bladder Cancer
- 1003546726-6727 A Renewal Application From Geoffrey L. Brinkman, M.D. - No. 561r1.
- 1003546728-6743 Application for Renewal of Research Grant the Effect of Cigarette Smoking on the Ultramicroscopic Structure the Bronchial Mucosa
- 1003546744-6745 A Renewal Application From Kenneth M. Lynch, M.D., and Forde A. Mciver, M.D. - No. 566-R1.
- 1003546746-6751 Application for Renewal of Research Grant Evironmental Factors and Pulmonary Carcinogenicity
- 1003546752-6753 Renewal Application From Lucio Severi, M.D. - No. 567-R1.
- 1003546754-6762 Application for Renewal of Research Grant An Approach to the Study of Internal Factors in Lung Carcinogenesis. Influence of Hormones.
- 1003546763-6764 A Renewal Application From Kenneth M. Moser, M.D. - No. 569-R1.
- 1003546765-6774 Application for Renewal of Research Grant Smoker-Non-Smoker Differencer in Activation of Fibrinolytic-Coagulation Systems.
- 1003546775-6776 First Renewal Application From Clayton G. Loosli, M.D. - No. 573r1.
- 1003546777-6780 Application for Renewal of Research Grant Lung Tissue Reactions to Airborne Chemical and Biological Agents
- 1003546781-6783 Request for A Supplementary Grant From Freddy Homburger, M.D. - No. 456r2.
- 1003546784 Application for Research Grant
- 1003546785-6786 Request for Supplementary Grant From Thomas C. Westfall, A.B., M.S., Ph.D. - No.467r2-S.
- 1003546787-6810 Application for Research Grant Supplemental Grant Request
- 1003546811-6813 A Modified Proposal From Ernest Clark,Ph.D. And Donald B. Giddon, D.M.D., Ph-D.-No. 613-M.
- 1003546814-6817 Application for Renewal of Research Grant A Psychophysiological Study of the Act of Reaching for A Cigarette.
- 1003546818 Request for Grant Supplement From John E. Craighead, M.D. Of Harvard Medical School - No. 550-S.
- 1003546819-6820
- 1003546821-6823 New Research From Freddy Homburger - No.338-A.
- 1003546824-6832 Application for Research Grant Bioassay of Tobacco Smoke Condensates and Related Problems
- 1003546833-6834 New Application From Walter Redisch, M.D. - No. 626.
- 1003546835-6850 Application for Research Grant (the Effect of Cigarette Smoking on Peripheral Blood Flow in Patients with Essential Hypetension, Untreated and Treated)
- 1003546851-6859 Application for Research Grant Effects of Tobacco Smoking and Nicotine on the Central Nervous System
- 1003546860-6864 New Grant Application From Jack P. Strong, M.D. - #632.
- 1003546865-6867
- 1003546868-6878 Application for Research Grant Relationship of Smoking and Other Environmental Factors to Atherosclerotic Lesions
- 1003546879 Relationship Between Smoking Habits and Coronary Atherosclerosis in Autopsied Males
- 1003546880-6882
- 1003546883
- 1003546884 the 39th Scientific Session of the American Heart Association, New York City, 661021-661028. Also the American Society for the Study of Arteriosclerosis and the Council on Arteriosclerosis of the American Heart Association, 661019 - 661020
- 1003546885-6886
- 1003546887
- 1003546888-6889
- 1003546890
- 1003546891-6893
- 1003546894-6896 A New Grant Application From John R. Rowlands,Ph.D. - No. 611.
- 1003546897-6905 Application for Research Grant Senior Research Scientist
- 1003546906-6912
- 1003546913
- 1003546914-6925 Proposal 5-4727a for Esr Studies of Biochemical Effects of Atmospheric Pollutants
- 1003546926-6946 the Effects of Tobacco Smoke on Lung Tissue As Measured by Electron Spin Resonance
- 1003546947-6948 New Grant Application From Irving Geller, Ph.D. - No. 622.
- 1003546949-6961 Application for Research Grant Effects of Nicotine on Learning in Laboratory Animals
- 1003546962-6963 New Grant Application From Walter B. Essman, Ph.D. - No 623
- 1003546964-6974 Application for Research Grant Studies of Nicotine Action Upon Memory Consolidation
- 1003546975-6977 New Grant Application From John E. Noakes, Ph.D. - No. 624.
- 1003546978-6995A Application for Research Grant 'po-210 in Tobacco'
- 1003546996-6997
- 1003546998-7007 Application for Research Grant Nicotine Effect Upon Cardiac Membrane Enzymes
- 1003547016-7018 New Grant Application From Fritz K Beller, Md., SC.D. - 627.
- 1003547019-7030 Application for Research Grant the Influence of Tobacco Smoking on Intravascular Protelysis
- 1003547031-7032 New Grant Application From Theodore N. Finley, M.D. And Aaron J. Ladman, Ph.D. -No. 628.
- 1003547033-7042 Application for Research Grant Effect of Cigarette Smoking on Lipids and Morphology of Alveolar Lining Material and Macrophages
- 1003547043-7044 New Grant Application From Carlton K. Erickson, Ph.D. - No. 629.
- 1003547045-7054 Application for Research Grant Mechanism of Learning Facilitation by Nicotine
- 1003547055-7056 New Grant Application From Mary Stearns Parshley, Ph.D. - No. 630.
- 1003547057-7069 Application for Research Grant Effects of Constituents of Tobacco Smoke on Normal and Malignant Human Respiratory Epithelium in Vitro.
- 1003547070-7071 Equipment Grant Application From Savl Boyarsky, M.D. Of Duke University Medical School - No. 633.
- 1003547072-7082 Application for Research Grant Nicotine Effect on Ureter in Man: A Possible Therapy for Hydronephrosis.
- Characteristic
- EXTR, EXTRA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- uhw02a00
Document Images
Application for Research Grant
NICOTINE EFFECT UPON CARDIAC' MEMBRANE ENZYMES
Harry Darrow Brown
The University of Texas Medical Branch at Galveston
Galveston, Texas 77550
713 - SO 5 - 1107

Diazacholesterol effect upon membrne ATPase
HARRY DARROW BROWN, SWARAJ K. CHATTOPADHYAY and ANIL B. PATEL'
:Galveston Texas
Conditions resembling myopathy have been induced in experimental animals by
the administration of steroids. Response of animals to these compounds has been
reported as characteristically a moderate to severe muscular weakness bearing a
after contraction, indistinguisha?;le from naturally occurring rrnyotonia.
~ and in the goat reported that the drug induced a delayed muscle fiber relaxation
similarity to myotonia.la 2 Winer, et al.3 using 20, 25 diazacholesteroli in man
We have found in man and in ;he duck4t 5 that certain, myopathic states can be
correlated with an altered respor.se to the cardiac glycoside, ouabain, of rnembrane-
skeletal muscle. In the present study we undertook a proionged' administration of
bound ATPase from erythrocyte ghosts and! from the sarcoplasmic reticulum of
20, 25 diazacholesterol to rabbits while monitoring the response of isolated erythro-
ATPase preparations was assayed at the termination of the treatment period.
cyte-ghosts ATPase to ouabain. Effect of the drug course upon muscle membrane
Fifteen male rabbits (6-7 lbs.) were used in three groups. Each animal from
Group I was treated with a 5 mg daily dose of 20, 25 diazacholesterol in 1 ml of
water daily. The control Group I1'_. was maintained upon a daily administration of
of the drug which were progressively increased from 10 mg to 50 mg in 1 mii of
water intramuscularly. Similarly, animals from Group II were given higher doses
1 ml of distilled water.
From the Biochemistry Departmezt, The University of Texas Medical Branch at
Galveston, Texas.

Nine to ten ml of blood was collected in a glass tube containing 10 ml haemo-
lyzing solution ( Tris buffer, 0.002'M, pI-: 7.4, with 0.005 M Na2EDTA ) from each
animal. Blood samples were co;ic ::od before the treatment and~ after 7, 8, 1'.' and
13 days of administration. Ske1, <: muscle samples were collected after 16 days
of drug therapy. Each time, trc :''Iod' haemolyzate was centrifuged at 20, 000 x g
for 20 minutes,` The supernatant .:.s discarded and the pellet washed and recen-
, : r ..~
trifuged 4 to 5 times in the same ',is buffer, and 2mM NaC1. Before each wash
p waer
theellets hornognized in a I;c.xer driven Teflon-pestle homogenizer fo 5
minutes to ensure complete disi,i ion of blood cells. The reddish-white pellet
obtained in final centrifugation wa_- collected and stored at -10°C as the erythro-
cyte ghost preparation, and used as the source of ATPase activity.
Muscles were macerated~ in 10 volumes of 0.1 M cold Tris buffer, pH 7.2,
with 0.25 M sucrose preliminary to separation of the membrane fractions by centri-
' fiigation. The slurry was first cerLtrifuged 600 x g for 20 minutes. The pellet was
rejected and~ the supernatant dialyzed against the same Tris-sucrose buffer with~
5 mM Na2EDTA for 4 hours. Afte-=ward the dialysates were centrifuged 10, 000 x
g and 20, 000 x g for 30 minutes, and'i each time the pellets were discarded. This
supernatant was then centrifuged in 10 ml tubes at 80, 000 x g for 30 minutes and
again 100, 000 x g for 70 minutes. The 100, 000 x g pellet was resuspended in 2 ml-
Tris-sucrose buffer, pH 7.2, as the enzymatically active fraction ( sarcoplasmic
reticulum ) .
ATPase activity was measured as inorganic phosphate evolved in reaction
mixtures containing 0.1 ml of enzyane preparation (ghost or membrane fraction
0.8 ml substrate ( 0.1 M Tris-sucrose buffer, pH 7.2, with~ Na2ATP r0.3 mg/ml
of reaction mixture~ together with 0.001 M MgC12, 0.0021VI KCl, 0.001 M NaCl ),
0.1 ml water or of inhibitor in water. Multiple reactions were run so that they
might be taken as samples in sequence to allow consideration of the extent of reaction
as a function of time. Reaction mixtures were incubated at 42°. After incubation,
i
0.1 ml of 50170 trichloroacetic acid was added and the mixture was centrifuged at ~
600 x g for 6 minutes. The supernatant was assayed~ for inorganic phosphate. C
Protein was determined in sample aliquots of the enzyme preparation. 0
C4
~
~
~

Blood was drawn from each of thc- animals before the initiation of the admin-
istration of diazacholesterol .' At this time erythrocyte -ghost ATPase activity
tvas inhibited by 10-4.IVf ouabain in the incubation mixture, without exception.
' In the first experimental group, animals receiving 5 mg daily doses, the erythro-
cyte adenosine triphosphatase activity was stimulated by ouabain, rather than
'inhibited as were the control preparations. This was true also of preparations
from blood of rabbits in experimental Group II, which had received larger doses.
These data are presented in Table I.
Muscular weakness began the 4th day of drug administrati= and became pro-
gressively severe. This was accompanied by an apparent muscle atrophy.
Figure 1 A is a graphic representation of the result of a series of experiments
in which the catalytic activity was inhibited by 10-41VI' ouabain. Identical experi-
in which ATPase activity of ghosts was plotted as a function of time and compared~
(dotted line ) with a similar series, using ghosts prepared' from the same animal,
reticulum ) ATPase was similar to that apon the red-blood-cell ATPase; enzyme
The results of the drug course upon tInc t00, 000 x g muscle fraction~ ( sarcoplasrnicc
effect of ouabain here was to stimLlatc: rather than to inhibit the ATPase activity.
ministration of 20, 25 diazacholesterol LLre presented by Figures 1 B and 1 C. The
ments using preparations from anirnals which had been carried on courses of ad-
stimulated. Data obtained in representative series of experiments is presented in
activity of'control animals was inhibited while that of the experimental animals was
Figure 2.
The characteristic response of membrane ATPase systems to ouabain is an
inhibition of the rate of catalytic hydrolysis of ATP. Enzymatic activity of ghost
preparations and a muscle merrnbrane fraction from untreated rabbits was inhibited
by ouabain. Sustained treatment of animals with 20,25 dYazacholesterol changed
the character of the ATPase activity such that a stimulation of the catalytic rate
was effected by the presence of ouabain in the incubation mixture. We have

suggestedb, I that the ATPase respons:, to ouabain is a reflection of the conformation
of the enzyme which it derives in part from, its association withi the membrane.
Myopathic changes in skeletal,muscle following the administration of cortico-
steroids has been discussed by Awad, ct al.1- In their experimental work the
possibility_of neural induction of the observed myopathy was eliminated and they
concluded that steroid myopathy is a primary muscular disorder.
.The use of 20,25 diazacholesteroi as a cholesterol lowering agent was discon-
tinued in medical, practice when, it became known that the site of action was at the
_point of coiiv~rsion of desmosterol to cholesterol resulting in the accumulation of
desmosterol. The present results wL'.:.?z show an effect upon membrane related! ion
,transport enzyme (Na+ + K+ -ATPase: may provide an element of support to the
: thesis that diazacholesterol causes myatonia by affecting the muscle membrane
system. Such an effect could conceiva:)iy follow a change in the lipid pool from
which the membrane elements in turn, are synthesized. It is known that the ATPase
interrelationship of lipid pool to functional membrane is a matter which requires,
activity is affected by changes in the lipid components of the membrane 8 The
and is subject to, direct experimental test.
Rabbits in the experimental groups visibly showed indications of changes in
muscle tone which may relate to the observations of Winer, et al 3 that the diaza-
- cholesterol is capable of inducing myotonia. The transport ATPase response to
ouabain which we have found in erythrocytes from myotonic patients4 is paralleled
port phenomena and appears to indicate that diazacholesterol adrninistration directly
affects the membrane transport system.
f4id'i.ngs a-ccord _with the common supposition that myotonia involves aberrant trans-
by the present experimental results in nhe diazacholesterol-treated rabbit. These
5

Table I'. Effects of ouabain upon a:"' Psse activity# ( µmoles Pi/mg Protein/min )
_
Group II progressively increasing c;oses 10-50 mg/day; Group III, controls.)
of erythrocyte ghosts .( Group I a~: :~als received 5 mg diazacholesteroL/day
6 140 mg
_10
Group .roup III.
360 mg
140 mg
360 mg
180 mg
36&mg
360 mg
- 310 mg
360 mg
Activity
Control Ouabain 10-4 M % stimulation
inhibition
0.20 0.27 +35
0.22 0.26 +18
0.16 0.17 + 6
0.19 0.21 +10
0.48 0.47 - 2.
0.26 0.39 +50
0.19 0.19 + 0
0.40 0.59 +47
0.35 +52
0.21 0.25
0.39 0.36
0.13 0.15' +15
0.32 0.36 +12
0.29 0.46
0.28 0.55
0.24 0.49
+58
+96
+ 104
0.15 0.24 +60
0.21 0.32 +52
0.14 0.11 -21
0.16 6.11 -.25
0.14 0.06 -57
0.15 0.12 -20
0.44 ' 0.28 - 36
*
Upon the basis of 40 minute incubation.

REFERENCES
. Faludi, Georgina, Mills, Lew~is C., and Chayes, Zev W.: Effect of
steroids on muscle, Acta Endocrinologica 45: 68-78, 1964.
. Awad, Essam A., Swaiman~ Kenneth F., and Kittke, Frederic J.:
Changes in the structure, innervation, electromyographic patterns
;` and enzymes of skeletal muscle resultind from experimental treatment
with triamcinolone, Arch. Physical Med. and''Rehabilitation 46: 297,
1965 Y }
. Winer, Nathaniel, Martt,, Jack M., Somers,' John E., Wolcott, Lester, °
Dale, Homer E., and Burns, Thomas W.: Induced myotonia in man
aad goat, J. of Laboratory and Clin. Med. 66: 758-769, 1965.
. Brown, H. D., Chattopadhyay, S. K., and Patel, A. B. Erythrocyte ab-
normality in human myopatl-: yT . Ms. submitted,.
. Brown, H. D., Chattopadr yay. S. K., Patel, A., and Rigdon, R. H.:
: Glycoside effect upon n-.enz:;:-:ne enzymes of erythrocytes and muscle
in duck myopathy. Expcric_ , ia, in press.
. Brown, H. D.: A chasacterizarion of the ouabain sensitivity of heart
microsomal ATPase. Bioch. Bioph. Acta 120: 162-165, 1966.
. Brown, H. D., Neucere, N. J.,, Altschul, A. M., and Evans, W. J.:
Activity patterns of purified ATPase from Arachis, Life Sciences 4:
1439-1447, 1965. .. .
. Schatzmann, H.,J.: Lipoprotein nature of red cell adenosine triphosphatase,
Nature 196: 677, 1962.
a
,,
1;
1:r
4
rk!
.14i'.:
11
" . .. . . . . V .. ~ . ~a I
,

Y:n!
r
1s
,
s.
t
(Abstzact )
. . . .. _ .. . .. . .. . . - . _ . '. . ..v..
ATPase activity of erythrocytee ghost prer.arations and of a muscle membrane
fraction (sarcoplasmic reticulum )-frornl untreated r~.bbits was inhibi'ted by the
cardiac glycoside, ouabain.. Sustained treatment of animals with 20,25 diaza-
~.
,_ . . .~.,
cholesterol, reported by Winer e`t al.,( this Journal, 66: 758, 1965) to in-, " R.
,<duce myotonia, changed the character of the ATPase activity of identical
. .. . . ' . . . . :Y:
preparations such that a stimulation of the catalytic rate was effected by the
. presence of ouabain in the incubation mixture. We have earlier suggested
that the ATPase response to ouabain is a reflection of the conformation of the
enzyme which it derives in part from its association with the membrane. The
'present findings accord with the common supposition that myotonia involves
.`aberrant transport phenomena and~ appears to indicate that` diazacholesterol
administration directly affects the membrane transport systemi.
;sq
vr.
X!
fu
.,,
w!
s
s.
r
x
. ... , ._. .., . _ .
., , .. , _ .. - . _ . .
